Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001144204-16-124477

Director acquired 120,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Runge Jeffrey W. · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2016-09-15 Exercise or conversion : show line 1 in the form +20,000 $1.35 $27,000 57,700 D
2016-09-15 Exercise or conversion : show line 2 in the form +20,000 $1.60 $32,000 77,700 D
2016-09-15 Exercise or conversion : show line 3 in the form +20,000 $1.45 $29,000 97,700 D
2016-09-15 Exercise or conversion : show line 4 in the form +20,000 $1.64 $32,800 117,700 D
2016-09-15 Exercise or conversion : show line 5 in the form +20,000 $1.51 $30,200 137,700 D
2016-09-15 Exercise or conversion : show line 6 in the form +20,000 $1.69 $33,800 157,700 D

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2016-09-15 Exercise or conversion : show line 7 in the form Employee Stock Option (right to buy) −20,000 0 D
2016-09-15 Exercise or conversion : show line 8 in the form Employee Stock Option (right to buy) −20,000 0 D
2016-09-15 Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) −20,000 0 D
2016-09-15 Exercise or conversion : show line 10 in the form Employee Stock Option (right to buy) −20,000 0 D
2016-09-15 Exercise or conversion : show line 11 in the form Employee Stock Option (right to buy) −20,000 0 D
2016-09-15 Exercise or conversion : show line 12 in the form Employee Stock Option (right to buy) −20,000 0 D
Loading xslF345X03/v449073_4.xml…